Seres Therapeutics MCRB
NASDAQ MCRB
$2.09 -0.04 (-1.88%)
At close: Oct 23, 2026 · 4:00 PM EDT

Seres Therapeutics (MCRB) Price to Earnings (2024 - 2025)

Updated

Seres Therapeutics' (MCRB) Price to Earnings was 24.96 for Q4 2025, down 97.6% from 1057.13 a year earlier and down 20.1% from the prior quarter.

Analysis

Seres Therapeutics (MCRB) Price to Earnings (2024 - 2025) Analysis & Trends

Dating back to Q4 2024, Seres Therapeutics' Price to Earnings record includes 5 quarters.

  • By year, Price to Earnings came in at 1057.13 in FY2024.
  • Five-year quarterly Price to Earnings spans a low of 1.13 in Q2 2025 and a high of 1057.13 in Q4 2024.
  • Per Business Quant data, the three quarters before Q4 2025 came in at 31.26 (Q3 2025), 1.13 (Q2 2025) and 1.68 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Seres Therapeutics 20.54 Mn -118.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 24.96
Sep 30, 2025 31.26
Jun 30, 2025 1.13
Mar 31, 2025 1.68
Dec 31, 2024 1,057.13
API Access

Seres Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=MCRB&period=max&api_key=YOUR_API_KEY